The Collaborative immunology CRO
Enriching your team
We can tell your molecule’s story
Our mission is to unlock discoveries and develop solutions for biopharmaceutical companies seeking to overcome substantial scientific challenges by providing data of outstanding quality
We’re so pleased to announce that in 2023 we’ll be exhibiting and presenting at two prestigious conferences:
Register for our webinar to hear directly from our CSO, Dr. Agapitos Patakas on the topic of T cell exhaustion and modelling this in cell-based assays.
Read our latest news and browse our scientific resource articles
Antibody Analytics is thrilled to announce that we have been shortlisted in Scotland's Life Sciences Annual Awards in the 'Innovation Pharma Services and Drug Discovery' category.
Our Treg suppression assay formats are adaptable, using natural Tregs isolated from PBMCs, or induced Tregs expanded and differentiated from naïve CD4+ T cells.
Antibody Analytics has established an in vitro T cell exhaustion model that can be used to assess candidate immunotherapeutics. Find out more about our unique approach.
Target cells are a critical component of immune cell effector assays. Whether investigating T cell dependent cellular cytotoxicity (TDCC) or antibody dependent cellular cytotoxicity (ADCC), we create engineered target cells uniquely suited for the evaluation of effector function and molecule specificity. But how do we achieve this and what are the principles we follow?